Sandip Kapadia
Overview
Sandip Kapadia received $6M in total compensation, including $354K in salary, at Harmony Biosciences Holdings in 2021. Sandip Kapadia also received an average of $2M at Intercept Pharmaceuticals from 2016 to 2021.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
Harmony Biosciences HoldingsEVP and Chief Financial Officer
Intercept PharmaceuticalsFormer CFO
Intercept PharmaceuticalsChief Financial Officer and Treasurer
Intercept PharmaceuticalsChief Financial Officer and Treasurer
Intercept PharmaceuticalsChief Financial Officer and Treasurer
Intercept PharmaceuticalsChief Financial Officer
Intercept PharmaceuticalsChief Financial Officer
Source: SEC filings on April 8, 2022, May 2, 2022, April 27, 2021, April 29, 2020, April 30, 2019, and April 27, 2018.
Related executives
We found 21 more executives who work or worked at Harmony Biosciences Holdings and Intercept Pharmaceuticals.
Jerome Durso
Intercept Pharmaceuticals
Chief Executive Officer
Jared Freedberg
Intercept Pharmaceuticals
General Counsel
Michelle Berrey
Intercept Pharmaceuticals
Chief Medical Officer
Gail Cawkwell
Intercept Pharmaceuticals
SVP Medical Affairs, Safety & Pharmacovigilance
Andrew Saik
Intercept Pharmaceuticals
Chief Financial Officer
Jeffrey Dierks
Harmony Biosciences Holdings
EVP and Chief Commercial Officer
John Jacobs
Harmony Biosciences Holdings
Chief Executive Officer
Rocco Venezia
Intercept Pharmaceuticals
Chief Financial Officer
News
Intercept Pharmaceuticals CEO Jerome Durso's 2021 pay jumps 101% to $7.9M
May 2, 2022
Harmony Biosciences Holdings CFO Sandip Kapadia's 2021 pay jumps 171% to $6.2M
April 8, 2022
Intercept Pharmaceuticals CEO Mark Pruzanski's 2020 pay slips 3% to $6.4M
April 27, 2021
Intercept Pharmaceuticals CEO Mark Pruzanski's 2019 pay jumps 46% to $6.6M
April 29, 2020
Intercept Pharmaceuticals CEO Mark Pruzanski's 2018 pay falls 26% to $4.5M
April 30, 2019